ArticleJournal of molecular histology2025
Modulation of placental inflammation by Azadirachta indica in rat models of diabetes-induced maternal and fetal complications.
Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maternal diabetes mellitus (MDM) is associated with an increased risk of fetal and placental malformations compared with normal pregnancies. The leaf extract of Azadirachta indica (neem) has been employed as a bioactive agent with proven antidiabetic potential. Beyond its hypoglycemic effects, neem extract has been reported to reduce inflammatory markers, ameliorate insulin resistance, and enhance blood circulation. In the present study, pregnant female rats were allocated into four experimental groups: (I) control (C), (II) neem-treated (N), (III) type 2 diabetes mellitus-induced (D), and (IV) diabetic pregnant rats treated with neem extract (D + N). Diabetic dams exhibited marked elevations in serum glucose, insulin, and lipid profile parameters. Moreover, a significant increase in IFN-γ and IFN-γ/IL-10 ratio, accompanied by a significant reduction in IL-10 levels, was recorded in comparison with controls. Treatment of diabetic dams with neem extract resulted in significant improvements in maternal body weight, reproductive performance, and fetal morphology relative to untreated diabetic rats. Histopathological examination of placental tissues revealed that neem supplementation normalized the decidual layer, increased its thickness, and enhanced the structure of the junctional zone (JZ) and labyrinth zone (LZ) compared to diabetic controls. In conclusion, administration of Azadirachta indica leaf extract demonstrated protective effects against diabetes-induced alterations in pregnancy. It improved maternal metabolic and inflammatory profiles, enhanced reproductive outcomes, and preserved the histological integrity of placental tissues in diabetic rats.
Indexed as
Identifiers
41361020What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.